CAMBRIDGE, Mass. (AP) — COVID-19 vaccine sales helped Moderna triple its net income in a better-than-expected first quarter.
The vaccine maker said Wednesday that revenue from its coronavirus preventive shots jumped to $5.92 billion, from $1.73 billion in last year’s quarter, when the vaccines were debuting in most markets.
Moderna also is seeking authorization for its shots to be used in adolescents and children, something dozens of other countries have already granted. In the first quarter, Moderna earned $3.7 billion, compared with $1.2 billion in the same period last year.The results topped Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $5.18 per share.
While vaccine sales jumped compared to last year, they slid $1 billion from the fourth quarter of 2021, when customers sought boosters and many children began getting shots.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
First look: Hamsa, modern Israeli restaurant, opens May 11Sof Hospitality, owners of Doris Metropolitan and Badolina Bakery & Café debut their...
Les mer »
Moderna blows out first-quarter earnings expectations, triples Covid vaccine sales
Les mer »
Pfizer Q1 profit, revenue soar on COVID-19 vaccine salesCOVID-19 vaccine and treatment sales helped Pfizer breeze past Wall Street’s first-quarter expectations, as the drugmaker’s profit grew 61%.
Les mer »
Pfizer in Q1 Profit Leap of 61%BAGGING CASH: Sales of Pfizer coronavirus vaccine and treatment pushed the drugmaker past expectations in the first quarter as profit grew 61 percent.
Les mer »
Pfizer beats Q1 estimates as COVID vaccine and antiviral boost revenuePfizer Inc. undefined posted better-than-expected first-quarter earnings on Tuesday, boosted by sales of its COVID-19 vaccine and antiviral Paxlovid. The...
Les mer »
Pfizer Sales Soar on Covid-19 Vaccine SalesPfizer logged $25.7 billion in sales in the first-quarter, driven by sales of vaccine Comirnaty and Paxlovid, a pill aimed at reducing severe outcomes from Covid-19
Les mer »